Second Sight Medical Products Statistics
Share Statistics
Second Sight Medical Products has 50.74M
shares outstanding. The number of shares has increased by 0%
in one year.
| Shares Outstanding | 50.74M |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | n/a |
| FTD / Avg. Volume | n/a |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -2 and the forward
PE ratio is null.
Second Sight Medical Products's PEG ratio is
0.03.
| PE Ratio | -2 |
| Forward PE | n/a |
| PS Ratio | -137.16 |
| Forward PS | n/a |
| PB Ratio | 0.26 |
| P/FCF Ratio | -1.94 |
| PEG Ratio | 0.03 |
Financial Ratio HistoryEnterprise Valuation
Second Sight Medical Products has an Enterprise Value (EV) of -51.53M.
| EV / Sales | 396.35 |
| EV / EBITDA | 5.83 |
| EV / EBIT | 5.61 |
| EV / FCF | 5.6 |
Financial Position
The company has a current ratio of 28.64,
with a Debt / Equity ratio of 0.
| Current Ratio | 28.64 |
| Quick Ratio | 28.64 |
| Debt / Equity | 0 |
| Debt / EBITDA | -0.03 |
| Debt / FCF | -0.03 |
| Interest Coverage | -742.42 |
Financial Efficiency
Return on Equity is -13.07% and Return on Invested Capital is -13%.
| Return on Equity | -13.07% |
| Return on Assets | -12.6% |
| Return on Invested Capital | -13% |
| Revenue Per Employee | $-8,666.67 |
| Profits Per Employee | $-595,533.33 |
| Employee Count | 15 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 12K |
| Effective Tax Rate | -0.13% |
Stock Price Statistics
The stock price has increased by null% in the
last 52 weeks. The beta is 2.56, so Second Sight Medical Products's
price volatility has been higher than the market average.
| Beta | 2.56 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 5.84 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 30.48 |
| Average Volume (20 Days) | n/a |
Income Statement
In the last 12 months, Second Sight Medical Products had revenue of -130K
and earned -8.93M
in profits. Earnings per share was -0.82.
| Revenue | -130K |
| Gross Profit | -130K |
| Operating Income | -8.91M |
| Net Income | -8.93M |
| EBITDA | -8.84M |
| EBIT | -8.88M |
| Earnings Per Share (EPS) | -0.82 |
Full Income StatementBalance Sheet
The company has 69.59M in cash and 237K in
debt, giving a net cash position of 69.36M.
| Cash & Cash Equivalents | 69.59M |
| Total Debt | 237K |
| Net Cash | 69.36M |
| Retained Earnings | -328.58M |
| Total Assets | 65.65M |
| Working Capital | 54.8M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -9.19M
and capital expenditures -14K, giving a free cash flow of -9.2M.
| Operating Cash Flow | -9.19M |
| Capital Expenditures | -14K |
| Free Cash Flow | -9.2M |
| FCF Per Share | -0.84 |
Full Cash Flow StatementMargins
Gross margin is 100%, with operating and profit margins of 6853.08% and 6871.54%.
| Gross Margin | 100% |
| Operating Margin | 6853.08% |
| Pretax Margin | 6862.31% |
| Profit Margin | 6871.54% |
| EBITDA Margin | 6799.23% |
| EBIT Margin | 6853.08% |
| FCF Margin | 7078.46% |
